Inserm Transfert, a subsidiary of Inserm dedicated to technology transfer, and M2care are partnering to support the development of innovative start-ups emerging from Inserm laboratories. This partnership aims to combine the excellence of academic research with entrepreneurial expertise to transform scientific discoveries into clinical innovations beneficial to patients and public health. Together, they aim to create deeptech start-ups in healthtech, providing financial, strategic, and operational support to promising projects.
« M2care is committed to thoroughly examining
projects from Inserm Transfert's portfolio, perfectly aligned with our investment philosophy. This
partnership strengthens our ability to conduct preliminary analyses on valorization strategies and
enrich our project pipeline with high-quality projects while sharing best practices in the field. »
Florence Thueux
CEO M2care
